Budapest, Hungary

Mihály Barabás

USPTO Granted Patents = 2 

Average Co-Inventor Count = 23.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mihály Barabás: Innovator in Molecular Chaperone Production

Introduction

Mihály Barabás is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of molecular biology, particularly in enhancing cellular production of molecular chaperones. With a total of 2 patents, his work has implications for both pharmaceutical and cosmetic applications.

Latest Patents

Barabás's latest patents focus on methods for enhancing the production of molecular chaperones in cells. One of his key inventions involves a method of increasing the expression of a molecular chaperone by treating cells with specific hydroxylamine derivatives. This method can be applied to cells exposed to physiological stress, thereby increasing the stress response and enhancing chaperone activity. The hydroxylamine derivatives he developed correspond to specific chemical formulae, and his inventions also include novel derivatives and compositions that utilize these compounds.

Career Highlights

Mihály Barabás is associated with Cytrx Corporation, where he continues to innovate in the field of molecular biology. His research has garnered attention for its potential applications in improving cellular responses to stress, which is crucial for various therapeutic areas.

Collaborations

Barabás has collaborated with esteemed colleagues such as László Vígh and Péter Literáti Nagy. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Mihály Barabás stands out as an influential inventor in the realm of molecular chaperone production. His innovative methods and collaborations highlight the importance of research in enhancing cellular functions, paving the way for future advancements in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…